Veliparib With Temozolomide in Patients With Hematological Malignancies: Is There a Need to Adjust Dose?

Author(s): R. Singh, M. Gopalakrishnan, J. H. Beumer, M. A. Rudek, J. M. Greer, B. F. Kiesel, J. Karp, I. Gojo, J. Gobburu
Year:

Learn More LinkedIn Twitter Facebook Email